- Home
- SVV vs SPRY Comparison
SVV vs SPRY Comparison
Compare SVV & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVV
- SPRY
- Stock Information
- Founded
- SVV 1954
- SPRY 2015
- Country
- SVV United States
- SPRY United States
- Employees
- SVV N/A
- SPRY N/A
- Industry
- SVV Other Specialty Stores
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- SVV Consumer Discretionary
- SPRY Health Care
- Exchange
- SVV Nasdaq
- SPRY Nasdaq
- Market Cap
- SVV 1.2B
- SPRY 1.2B
- IPO Year
- SVV 2023
- SPRY N/A
- Fundamental
- Price
- SVV $7.00
- SPRY $12.49
- Analyst Decision
- SVV Buy
- SPRY Strong Buy
- Analyst Count
- SVV 6
- SPRY 4
- Target Price
- SVV $11.67
- SPRY $28.75
- AVG Volume (30 Days)
- SVV 828.2K
- SPRY 2.0M
- Earning Date
- SVV 05-08-2025
- SPRY 03-20-2025
- Dividend Yield
- SVV N/A
- SPRY N/A
- EPS Growth
- SVV N/A
- SPRY N/A
- EPS
- SVV 0.17
- SPRY 0.08
- Revenue
- SVV $1,537,617,000.00
- SPRY $89,149,000.00
- Revenue This Year
- SVV $7.05
- SPRY $41.49
- Revenue Next Year
- SVV $7.53
- SPRY $80.23
- P/E Ratio
- SVV $41.24
- SPRY $156.13
- Revenue Growth
- SVV 2.49
- SPRY 297063.34
- 52 Week Low
- SVV $6.48
- SPRY $7.55
- 52 Week High
- SVV $19.72
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- SVV 37.39
- SPRY 53.51
- Support Level
- SVV $6.85
- SPRY $12.08
- Resistance Level
- SVV $7.23
- SPRY $13.22
- Average True Range (ATR)
- SVV 0.34
- SPRY 0.91
- MACD
- SVV 0.15
- SPRY 0.12
- Stochastic Oscillator
- SVV 63.41
- SPRY 41.07
About SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, merchandise, and sells these items in its stores.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.